LAVAL, QC, Jan. 4 /CNW/ - Neptune Technologies & Bioressources Inc., (TSX.V: NTB), "Neptune" is pleased to announce very positive final results of the effect of Neptune Krill Oil (NKO(TM)) on adult Attention Deficit Hyperactivity Disorder (ADHD). The non-randomized Phase I open label clinical study, entitled "Evaluation of the effect of Neptune Krill Oil (NKO(TM)) on Attention Deficit Hyperactivity Disorder (ADHD)", was initiated by the International Organization of ADHD and conducted by Barry University in Miami Shores, FL, USA and private naturopath Clinics in Montreal, Quebec, Canada.
The objective of the study was to evaluate the effect of NKO(TM) on adult ADHD as measured by Barkley's Executive Function score of behaviour inhibition, daily functional capacity and social behaviour. Thirty (30) otherwise healthy adults with a confirmed diagnosis of ADHD taking a 500mg daily dose of NKO(TM) were originally enrolled in the study of whom 25 (83.3%) completed 6 months of treatment. The five (16.7%) patients who did not complete the study were lost in follow-up. No adverse events were reported amongst the 30 patients recruited at baseline during the course of their treatment.
According to the coimpany, after 6 months of treatment the 25 patients who completed the study showed a statistically significant improvement in all Barkley's Executive Function scores. In particular, patients improved their ability to concentrate and their working capacity by 60.2% (p(less than)0.001), their social skills by 48.8% (p(less than)0.001), their ability to manage money by 34.2% (p=0.004), their driving capacity and road-safety skills by 34.5% (p=0.011), their ability to focus by 39.0% (p(less than)0.001) and their planning skills by 50% (p=0.001).
About Neptune Technologies & Bioressources Inc.
Neptune Technologies & Bioressources Inc. develops high value added nutritional products from underexploited marine biomasses, such as krill, with its patented extraction process (Neptune OceanExtract(TM)). Using an exclusive process, Neptune Technologies & Bioressources Inc. is well positioned in the $182 billion global nutrition market (Nutrition Business Journal, Oct/Nov 2004) of health and wellness concepts.
Natural biomass extraction is now playing an important role in developing nutrigenomics, the next wave in nutritional research. Through strategic alliances and partnerships, as well as through clinical studies, the Company continues to demonstrate the immense beneficial effects of these products. The Company develops and markets new formulas and new products for specific applications in high growth markets such the nutraceutical, cosmeceutical, biopharmaceutical and nutrigenomics markets.
The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this news release.